Skip to Main Content

Author Details

Felipe Batalini
Mayo Clinic Arizona
2015
30
9
PMIDPaper TitleJournal TitlePublished Year
36711754Reciprocal inhibition of PIN1 and APC/C<sub>CDH1</sub> controls timely G1/S transition and creates therapeutic vulnerability.Res Sq2023
37806915Safety and Serum Estradiol Levels in Hormonal Treatments for Vulvovaginal Atrophy in Breast Cancer Survivors: A Systematic Review and Meta-Analysis.Clin Breast Cancer2023
38003387Metastatic ER+ Breast Cancer: Mechanisms of Resistance and Future Therapeutic Approaches.Int J Mol Sci2023
37992259Homologous Recombination Deficiency Landscape of Breast Cancers and Real-World Effectiveness of Poly ADP-Ribose Polymerase Inhibitors in Patients With Somatic <i>BRCA1</i>/<i>2</i>, Germline <i>PALB2</i>, or Homologous Recombination Deficiency Signature.JCO Precis Oncol2023
37211773Comparison of PARPi efficacy according to homologous recombination deficiency biomarkers in patients with ovarian cancer: a systematic review and meta-analysis.Chin Clin Oncol2023
37239141Targeting of microRNA-22 Suppresses Tumor Spread in a Mouse Model of Triple-Negative Breast Cancer.Biomedicines2023
36916193Therapy-related Myeloid Neoplasms Following PARP Inhibitors-Letter.Clin Cancer Res2023
35149538Phase 1b Clinical Trial with Alpelisib plus Olaparib for Patients with Advanced Triple-Negative Breast Cancer.Clin Cancer Res2022
35609495Artificial intelligence for prediction of treatment outcomes in breast cancer: Systematic review of design, reporting standards, and bias.Cancer Treat Rev2022
35369274An overview of artificial intelligence in oncology.Future Sci OA2022
35487638Response in <i>BRCA1</i> mutation carrier with metastatic pancreatic adenocarcinoma treated with FOLFIRINOX.BMJ Case Rep2022
36223740PARP-inhibition reprograms macrophages toward an anti-tumor phenotype.Cell Rep2022
36077867PARP Inhibitors for Breast Cancer: Germline <i>BRCA1/2</i> and Beyond.Cancers (Basel)2022
36048535Mutational Signature 3 Detected from Clinical Panel Sequencing is Associated with Responses to Olaparib in Breast and Ovarian Cancers.Clin Cancer Res2022
33146899Germline genetic testing in breast cancer: Rationale for the testing of all women diagnosed by the age of 60 years and for risk-based testing of those older than 60 years.Cancer2021
32923889Response of Brain Metastases From <i>PIK3CA</i>-Mutant Breast Cancer to Alpelisib.JCO Precis Oncol2020
35050731Challenges in Interpreting <i>TP53</i> Pathogenic Variants With a Low Minor Allele Frequency in Germline Genetic Testing: A Case Report of a Patient With Mosaic Li-Fraumeni Syndrome.JCO Precis Oncol2020
31900295Double-hit monomorphic B-cell lymphoma after liver transplantation.BMJ Case Rep2020
31008047Severe pulmonary toxicity from immune checkpoint inhibitor treated successfully with intravenous immunoglobulin: Case report and review of the literature.Respir Med Case Rep2019
38089365Overcoming barriers to resident scholarly productivity and research at a large academic institution.MedEdPublish (2016)2019
31533767Li-Fraumeni syndrome: not a straightforward diagnosis anymore-the interpretation of pathogenic variants of low allele frequency and the differences between germline PVs, mosaicism, and clonal hematopoiesis.Breast Cancer Res2019
31488440Haemodialysis-associated thrombocytopenia: interactions among the immune system, membranes and sterilisation methods.BMJ Case Rep2019
31256047Temozolomide-induced aplastic anaemia and incidental low-grade B-cell non-Hodgkin lymphoma in a geriatric patient with glioblastoma multiforme.BMJ Case Rep2019
28865972High-Dose Melphalan and Stem Cell Transplantation in Patients on Dialysis Due to Immunoglobulin Light-Chain Amyloidosis and Monoclonal Immunoglobulin Deposition Disease.Biol Blood Marrow Transplant2018
30567203Acute promyelocytic leukaemia presenting as necrotising fasciitis of the perineum (Fournier gangrene).BMJ Case Rep2018
30410725Cancer complaints: The profile of patients from the emergency department of a Brazilian oncology teaching hospital.F1000Res2017
27556323Off-Pump Triple Coronary Artery Bypass Grafting in a Patient with Situs Inversus Totalis: Case Presentation and a Brief Review of the Brazilian and the International Experiences.Braz J Cardiovasc Surg2016
26485499Improvement of Dream Enactment Behavior Associated With Levetiracetam Treatment in Dementia With Lewy Bodies.Alzheimer Dis Assoc Disord2016
25767581E-learning for neurosurgeons: Getting the most from the new web tools.Asian J Neurosurg2015
26338760Penetrating cardiac trauma by firearm: better outcomes and importance of prehospital care system.J Pak Med Assoc2015
  • 1 - 30 of 30

Recommended Authors

Eric Lu
David Geffen School of Medicine at university of california los angeles
Career Start Year 2017
Number of shared co-authors 0
Kevin Punie
Leuven Cancer Institute and University Hospitals Leuven
Career Start Year 2015
Number of shared co-authors 4
Zhengming Chen
Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 2013
Number of shared co-authors 0
Irbaz Bin Riaz
Mayo Clinic
Career Start Year 2012
Number of shared co-authors 1
Chen Hu
Johns Hopkins University School of Medicine
Career Start Year 2009
Number of shared co-authors 1
Gabriele Zoppoli
University of Genoa and Ospedale Policlinico San Martino
Career Start Year 2008
Number of shared co-authors 3
Julia A Beaver
Center for Drug Evaluation and Research
Career Start Year 2007
Number of shared co-authors 1
Bishoy M Faltas
Sandra and Edward Meyer Cancer Center
Career Start Year 2007
Number of shared co-authors 0
Catherine M Kelly
Mater Misericordiae University Hospital
Career Start Year 2006
Number of shared co-authors 1
Jordi Rodon
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 2
Alan H Bryce
Mayo Clinic
Career Start Year 2006
Number of shared co-authors 0
Shubham Pant
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 0
Aditya Bardia
Massachusetts General Hospital Cancer Center
Career Start Year 2004
Number of shared co-authors 4
Pavlos Msaouel
The University of Texas MD Anderson Cancer Center
Career Start Year 2004
Number of shared co-authors 0
Jochen K Lennerz
Massachusetts General Hospital/Harvard Medical School
Career Start Year 2004
Number of shared co-authors 0
David W Cescon
Princess Margaret Cancer Centre
Career Start Year 2003
Number of shared co-authors 2
Philippe L Bedard
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2002
Number of shared co-authors 2
Jes??s Garc??a-Donas
HM Hospitales-Centro Integral Oncologico Clara Campal
Career Start Year 2001
Number of shared co-authors 0
Richard B Schwab
Department of Medicine and Moores Cancer Center, University of California San Diego
Career Start Year 2000
Number of shared co-authors 0
Pingfu Fu
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 0
Martijn P Lolkema
Erasmus MC Cancer Institute
Career Start Year 1999
Number of shared co-authors 1
Elizabeth Garrett-Mayer
Center for Research and Analytics, American Society of Clinical Oncology
Career Start Year 1997
Number of shared co-authors 1
Nam Bui
Stanford University
Career Start Year 1996
Number of shared co-authors 0
Steven J Isakoff
Massachusetts General Hospital
Career Start Year 1995
Number of shared co-authors 2
Stefan Sleijfer
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Career Start Year 1994
Number of shared co-authors 0
Funda Meric-Bernstam
University of Texas MD Anderson Cancer Center
Career Start Year 1990
Number of shared co-authors 3
Joan Albanell
Hospital del Mar Research Institute
Career Start Year 1990
Number of shared co-authors 2
Mark Lawler
Queens University Belfast Belfast
Career Start Year 1988
Number of shared co-authors 0
Alberto Zambelli
IRCCS Humanitas Research Hospital
Career Start Year 1987
Number of shared co-authors 4
Stefan Aebi
University of Bern
Career Start Year 1985
Number of shared co-authors 1

Collaborators

Gerburg M Wulf
Co-authored papers 6
Eric P Winer
Dana-Farber Cancer Institute
Co-authored papers 3
Judy E Garber
Dana-Farber Cancer Institute
Co-authored papers 2
Yansheng Liu
Yale University School of Medicine
Co-authored papers 1
Nancy U Lin
Co-authored papers 1
Marisa Cobanaj
Polytechnic University of Milan
Co-authored papers 1
Giorgio P Biondetti
Co-authored papers 1
Alan D D'Andrea
Dana-Farber Cancer Institute
Co-authored papers 1
Lewis C Cantley
Co-authored papers 1
Andra Dombrovschi
Co-authored papers 1
Michael S Regan
Co-authored papers 1
Sara Marcu
Co-authored papers 1
Olmo Sonzogni
Co-authored papers 1
Peter J Park
Harvard Medical School
Co-authored papers 1
Federica Marian
Co-authored papers 1
Leo Anthony Celi
Harvard T.H. Chan School of Public Health, MIT
Co-authored papers 1
Nathalie Y R Agar
Co-authored papers 1
Edward Christopher Dee
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Ioannis S Vlachos
Harvard Medical School
Co-authored papers 1
Fergus J Couch
Mayo Clinic
Co-authored papers 1
Giuseppe Curigliano
University of Milan
Co-authored papers 1
Nathanael S Gray
Harvard Medical School
Co-authored papers 1
Maxwell R Lloyd
Beth Israel Deaconess Medical Center
Co-authored papers 1
Chiara Corti
University of Milano
Co-authored papers 1
Release 1.2